VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1–linked Parkinson’s neurons
Science Advances · 2026
DOI: 10.1126/sciadv.adz5645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Leonie M Heger und 14 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Dopaminergic Neurons, Parkinson Disease, Vesicular Monoamine Transport Proteins, Dopamine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Helmholtz Association, Hector Fellow Academy, European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme.
Abstract (Originalsprache)
Parkinson’s disease (PD) is characterized by α-synuclein accumulation and dopaminergic neuron degeneration, with dopamine (DA) oxidation emerging as a key pathological driver. However, the mechanisms underlying this neurotoxic process remain unclear. Using PD patient-derived and CRISPR-engineered induced pluripotent stem cell midbrain dopaminergic neurons lacking DJ-1, we identified defective sequestration of cytosolic DA into synaptic vesicles, which culminated in DA oxidation and α-synuclein pathology. In-depth proteomics, state-of-the-art imaging, and ultrasensitive DA probes uncovered that decreased vesicular monoamine transporter 2 (VMAT2) protein and function impaired vesicular DA uptake, resulting in reduced vesicle availability and abnormal vesicle morphology. Furthermore, VMAT2 activity and vesicle endocytosis are processes dependent on adenosine 5′-triphosphate (ATP), which is notably reduced in DJ-1–deficient dopaminergic neurons. ATP supplementation restored vesicular function and alleviated DA-related pathologies in mutant dopaminergic neurons. This study reveals an ATP-sensitive mechanism that regulates DA homeostasis through VMAT2 and vesicle dynamics in midbrain dopaminergic neurons, highlighting enhanced DA sequestration as a promising therapeutic strategy for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany.
- Graduate School of Systemic Neurosciences (GSN), LMU Munich, Munich, Germany.
- Abberior Instruments GmbH, Göttingen, Germany.
- Neuroproteomics, School of Medicine and Health, TUM University Hospital, Technical University of Munich, Germany.
- German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
ORCID-Profile: Leonie M Heger, Francesco Gubinelli, Aida Cardona-Alberich, Matteo Rovere, Ulf Matti, Stephan A Müller, Lena Jaschkowitz, Martina Schifferer, Wolfgang Wurst, Stefan F Lichtenthaler, Christian Behrends, Sivakumar Sambandan, Lena F Burbulla
Förderung
- Helmholtz Association
- Hector Fellow Academy
- European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme
- Germany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology
- Rise up! programme of the Boehringer Ingelheim Foundation
- DFG, Heisenberg programme
- Bundesministerium für Bildung und Forschung under the aegis of JPND
- Helmholtz AssociationGermany’s Excellence Strategy within the framework of the Munich Cluster of Systems Neurology
Zitieren
APA
Heger, L. M., Gubinelli, F., Huber, A. J., Cardona-Alberich, A., Rovere, M., Matti, U., Müller, S. A., Nagaraja, S. R., Jaschkowitz, L., Schifferer, M., Wurst, W., Lichtenthaler, S. F., Behrends, C., Sambandan, S., & Burbulla, L. F. (2026). VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1–linked Parkinson’s neurons. Science Advances. https://doi.org/10.1126/sciadv.adz5645
Vancouver
Heger LM, Gubinelli F, Huber AJ, Cardona-Alberich A, Rovere M, Matti U, et al. VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1–linked Parkinson’s neurons. Science Advances. 2026. doi:10.1126/sciadv.adz5645
BibTeX
@article{Heger2026,
author = {Heger, Leonie M and Gubinelli, Francesco and Huber, Andreas J and Cardona-Alberich, Aida and Rovere, Matteo and Matti, Ulf and Müller, Stephan A and Nagaraja, Sankarshana R and Jaschkowitz, Lena and Schifferer, Martina and Wurst, Wolfgang and Lichtenthaler, Stefan F and Behrends, Christian and Sambandan, Sivakumar and Burbulla, Lena F},
title = {VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1–linked Parkinson’s neurons},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.adz5645}
}
EUVIMED